Can I read Cost-Effectiveness of Dasatinib in CML on EtoBox?

Cost-Effectiveness of Dasatinib in CML by vosuong.2304 is a document available to read on EtoBox.

What is Cost-Effectiveness of Dasatinib in CML about?

This study evaluates the cost-effectiveness of dasatinib compared to high-dose imatinib for treating chronic myelogenous leukemia in patients resistant to standard imatinib. The results indicate that dasatinib offers better quality-adjusted life years (QALYs) and lower lifetime costs in chronic phase patients, while showing higher costs per QALY in advanced phases. Overall, dasatinib is deemed a more economically favorable treatment option for most imatinib-resistant CML patients.

Author

vosuong.2304

Language

EN